Tomo Lucijanić
- Co-authors
- Marko SkelinDario RahelićMarko LucijanićDaniela Amidžić KlarićHossein GharibRajko KušecIvica LukšićTajana Štoos‐Veić
- Topics
- COVID-19 Clinical Research Studies (4 papers)Long-Term Effects of COVID-19 (4 papers)Lipoproteins and Cardiovascular Health (2 papers)
- Journals
- The Science of The Total EnvironmentJournal of Medical VirologyInternational Journal of Cardiology
- Partner nations
- CroatiaUnited StatesItaly
In The Last Decade
Tomo Lucijanić
18 papers receiving 258 citations
Peers
Comparison fields: 5 of 75
- Endocrinology, Diabetes and Metabolism 84
- Infectious Diseases 52
- Epidemiology 42
- Molecular Biology 40
- Surgery 38
Countries citing papers authored by Tomo Lucijanić
This map shows the geographic impact of Tomo Lucijanić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomo Lucijanić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomo Lucijanić more than expected).
Fields of papers citing papers by Tomo Lucijanić
This network shows the impact of papers produced by Tomo Lucijanić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomo Lucijanić. The network helps show where Tomo Lucijanić may publish in the future.
Co-authorship network of co-authors of Tomo Lucijanić
This figure shows the co-authorship network connecting the top 25 collaborators of Tomo Lucijanić. A scholar is included among the top collaborators of Tomo Lucijanić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomo Lucijanić. Tomo Lucijanić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 7 | |
| 3 | 21 | |
| 4 | 2 | |
| 5 | 8 | |
| 6 | 18 | |
| 7 | 21 | |
| 8 | 3 | |
| 9 | 21 | |
| 10 | 30 | |
| 11 | 6 | |
| 12 | 20 | |
| 13 | 82 | |
| 14 | 18 | |
| 15 | 1 | |
| 16 | 1 | |
| 17 | 1 | |
| 18 | 4 |
About Tomo Lucijanić
Tomo Lucijanić is a scholar working on Endocrinology, Diabetes and Metabolism, Infectious Diseases and Internal Medicine, having authored 18 papers that have together received 269 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (4 papers), Long-Term Effects of COVID-19 (4 papers) and Lipoproteins and Cardiovascular Health (2 papers). The work is most often cited by research in Internal Medicine (22 citations), Endocrinology, Diabetes and Metabolism (84 citations) and Geriatrics and Gerontology (11 citations). Tomo Lucijanić has collaborated with scholars based in Croatia, United States and Italy. Frequent co-authors include Marko Skelin, Dario Rahelić, Marko Lucijanić, Daniela Amidžić Klarić, Hossein Gharib, Rajko Kušec, Ivica Lukšić, Tajana Štoos‐Veić, Vlatko Pejša and Boris Starčević. Their work appears in journals such as The Science of The Total Environment, Journal of Medical Virology and International Journal of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.